Treatment of anti-MDA5 autoantibody-positive juvenile dermatomyositis using tofacitinib.

ABSTRACT:

SUBMITTER: Sabbagh S 

PROVIDER: S-EPMC6821280 | biostudies-literature | 2019 Nov

REPOSITORIES: biostudies-literature